No abstract available
Keywords:
Allogeneic hematopoietic stem cell transplantation; Azacitidine; Blastic plasmacytoid dendritic cell neoplasm; Tagraxofusp; Treatment.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Azacitidine / administration & dosage*
-
Chemotherapy, Adjuvant / methods
-
Dendritic Cells / pathology
-
Hematologic Neoplasms / diagnosis
-
Hematologic Neoplasms / pathology
-
Hematologic Neoplasms / therapy*
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Male
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / therapy*
-
Recombinant Fusion Proteins / administration & dosage*
-
Skin Neoplasms / diagnosis
-
Skin Neoplasms / pathology
-
Skin Neoplasms / therapy*
-
Treatment Outcome
Substances
-
Recombinant Fusion Proteins
-
tagraxofusp
-
Azacitidine
Associated data
-
ClinicalTrials.gov/NCT03113643
-
ClinicalTrials.gov/NCT03485547
-
ClinicalTrials.gov/NCT04317781